These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 32130328

  • 1. OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study.
    Souza FC, Mocellin M, Ongaratto R, Leitão LAA, Friedrich FO, Silveira VD, Scotta MC, Pitrez PM, Pinto LA.
    Einstein (Sao Paulo); 2020; 18():eAO5262. PubMed ID: 32130328
    [Abstract] [Full Text] [Related]

  • 2. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children.
    Razi CH, Harmancı K, Abacı A, Özdemir O, Hızlı S, Renda R, Keskin F.
    J Allergy Clin Immunol; 2010 Oct; 126(4):763-9. PubMed ID: 20920766
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months.
    Gutiérrez-Tarango MD, Berber A.
    Chest; 2001 Jun; 119(6):1742-8. PubMed ID: 11399700
    [Abstract] [Full Text] [Related]

  • 4. Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels.
    Del-Río-Navarro BE, Luis Sienra-Monge JJ, Berber A, Torres-Alcántara S, Avila-Castañón L, Gómez-Barreto D.
    Allergol Immunopathol (Madr); 2003 Jun; 31(1):7-13. PubMed ID: 12573204
    [Abstract] [Full Text] [Related]

  • 5. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
    Jara-Pérez JV, Berber A.
    Clin Ther; 2000 Jun; 22(6):748-59. PubMed ID: 10929921
    [Abstract] [Full Text] [Related]

  • 6. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection].
    Liao JY, Zhang T.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):508-12. PubMed ID: 24857002
    [Abstract] [Full Text] [Related]

  • 7. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections.
    Esposito S, Bianchini S, Bosis S, Tagliabue C, Coro I, Argentiero A, Principi N.
    J Transl Med; 2019 Aug 23; 17(1):284. PubMed ID: 31443716
    [Abstract] [Full Text] [Related]

  • 8. [Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children].
    Gómez Barreto D, De la Torre C, Alvarez A, Faure A, Berber A.
    Allergol Immunopathol (Madr); 1998 Aug 23; 26(1):17-22. PubMed ID: 9585823
    [Abstract] [Full Text] [Related]

  • 9. OM-85 BV: primary versus secondary prevention.
    Collet JP, Boissel JP.
    Respiration; 1994 Aug 23; 61 Suppl 1():20-3. PubMed ID: 7800967
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.
    Schaad UB.
    World J Pediatr; 2010 Feb 23; 6(1):5-12. PubMed ID: 20143206
    [Abstract] [Full Text] [Related]

  • 12. Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study.
    Esposito S, Bianchini S, Polinori I, Principi N.
    Int J Environ Res Public Health; 2019 Mar 25; 16(6):. PubMed ID: 30934539
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
    Mameli C, Pasinato A, Picca M, Bedogni G, Pisanelli S, Zuccotti GV, AX-Working Group.
    Pharmacol Res; 2015 Jul 25; 97():79-83. PubMed ID: 25931316
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant.
    Collet JP, Shapiro P, Ernst P, Renzi T, Ducruet T, Robinson A.
    Am J Respir Crit Care Med; 1997 Dec 25; 156(6):1719-24. PubMed ID: 9412546
    [Abstract] [Full Text] [Related]

  • 17. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.
    Esposito S, Marchisio P, Prada E, Daleno C, Porretti L, Carsetti R, Bosco A, Ierardi V, Scala A, Principi N.
    Vaccine; 2014 May 07; 32(22):2546-52. PubMed ID: 24681270
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with OM-85 BV in upper and lower respiratory tract infections.
    Derenne JP, Delclaux B.
    Respiration; 1992 May 07; 59 Suppl 3():28-31. PubMed ID: 1439237
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.